Rapid improvement in spinal pain in patients with axial spondyloarthritis treated with secukinumab: primary results from a randomized controlled phase-IIIb trial

BACKGROUND: This study aimed to evaluate the efficacy and safety of secukinumab 150 mg compared with placebo in the management of spinal pain and disease activity in patients with axial spondyloarthritis (axSpA) at Week 8 and up to Week 24. METHODS: Patients (n = 380) with active axSpA were randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Poddubnyy, Denis, Pournara, Effie, Zielińska, Agnieszka, Baranauskaite, Asta, Jiménez, Alejandro Muñoz, Sadhu, Sanchayita, Schulz, Barbara, Rissler, Michael, Perella, Chiara, Marzo-Ortega, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544765/
https://www.ncbi.nlm.nih.gov/pubmed/34707696
http://dx.doi.org/10.1177/1759720X211051471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544765/
https://www.ncbi.nlm.nih.gov/pubmed/34707696
http://dx.doi.org/10.1177/1759720X211051471

Ejemplares similares